NMDA receptor/amyloid precursor protein interactions: A comparison between wild-type and amyloid precursor protein mutations associated with familial Alzheimer's disease

Neuroscience Letters

Volumn 515, Issue 2, 2012, Pages 131-136

  Innocent, Neal ^a   Cousins, Sarah L ^a   Stephenson, F Anne ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Familial APP mutations; NMDA receptors

Indexed keywords

AMYLOID PRECURSOR PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B;

ALZHEIMER DISEASE; ARTICLE; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; MAMMAL CELL; MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; WILD TYPE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; HEK293 CELLS; HUMANS; MUTATION; PROTEIN SUBUNITS; PROTEIN TRANSPORT; RECEPTORS, N-METHYL-D-ASPARTATE; TRANSFECTION;

EID: 84859772884     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.03.029     Document Type: Article

References (23)

1. Bettens K., Sleegers K., Van Broeckhoven C. Current status on Alzheimer disease molecular genetics: from past, to present, to future. Hum. Mol. Genet. 2010, 19:R1-R11.
2. Boon W.C., van den Buuse M., Wegener N., Martin S., Chua H.K., Bush A.I., Masters C.L., Adlard P.A., Li Q.X. Behavioural phenotype of APPC100.V717F transgenic mice over-expressing a mutant Aβ-bearing fragment is associated with reduced NMDA receptor density. Behav. Brain Res. 2010, 209:27-35.
3. Cabrejo L., Guyant-Maréchal L., Laquerriere A., Vercelletto M., De La Fourniere F., Thomas-Anterion C., Verny C., Letournel F., Pasquier F., Vital A., Checler F., Frebourg T., Campion D., Hannequin D. Phenotype associated with APP duplication in five families. Brain 2006, 206:2966-2976.
4. Chazot P.L., Cik M., Stephenson F.A. Immunological detection of the NMDAR1 glutamate receptor expressed in human embryonic kidney cells. J. Neurochem. 1992, 59:1176-1178.
5. Cik M., Chazot P.L., Stephenson F.A. Optimal expression of cloned NMDAR1/NMDAR2A heteromeric glutamate receptors: a biochemical characterization. Biochem. J. 1993, 296:877-883.
6. Cousins S.L., Papadakis M., Rutter A.R., Stephenson F.A. Differential interaction of NMDA receptor subtypes with the PSD-95 family of MAGUK proteins. J. Neurochem. 2008, 104:901-913.
7. Cousins S.L., Hoey S.A.E., Stephenson F.A., Perkinton M.S.J. Amyloid precursor protein 695 associates with assembled NR2A- and NR2B-containing receptors to result in the enhancement of their cell surface delivery. J. Neurochem. 2009, 111:1501-1513.
8. Dewachter I., Filipkowski R.K., Priller C., Ris L., Neyton J., Croes S., Terwel D., Gysemans M., Devijver H., Borghgraef P., Godaux E., Kaczmarek L., Herms J., Van Leuven F. Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice. Neurobiol. Aging 2009, 30:241-256.
9. Groc L., Heine M., Cousins S.L., Stephenson F.A., Lounis B., Cognet L., Choquet D. NMDA receptor surface trafficking depends on NR2A/NR2B subunits. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:18769-18774.
10. Hawkins L.M., Chazot P.L., Stephenson F.A. Biochemical evidence for the co-association of three N-methyl-d-aspartate (NMDA) R2 subunits in recombinant NMDA receptors. J. Biol. Chem. 1999, 274:27211-27218.
11. Hoe H.-S., Fu Z., Makarova A., Lee J.-Y., Lu C., Feng L., Pajoohesh-Ganji A., Matsuoka Y., Hyman B.T., Ehlers M.D., Vicini S., Pak D.T.S., Rebeck G.W. The effects of amyloid precursor protein on post-synaptic composition and activity. J. Biol. Chem. 2009, 284:8495-8506.
12. Jacob C.P., Koutsilieri E., Bartl J., Neuen-Jacob E., Arzberger T., Zander N., Ravid R., Roggendorf W., Riederer P., Grunblatt E. Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease. J. Alzheimers Disease 2007, 11:97-116.
13. McNaughton D., Knight W., Guerreiro R., Ryan N., Lowea J., Poulter M., Nicholl D.J., Hardy J., Revesz T., Lowe J., Rossor M., Collinge J., Mead S. Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series. Neurobiol. Aging 2012, 33:426-434.
14. Mishizen-Eberz A.J., Rissman R.A., Carter T.L., Ikonomovic M.D., Wolfe B.B., Armstrong D.M. Biochemical and molecular studies of NMDA receptor subunits NR1/2A/2B in hippocampal subregions throughout progression of Alzheimer's disease pathology. Neurobiol. Disease 2004, 15:80-92.
15. Papadakis M., Hawkins L.M., Stephenson F.A. Appropriate NR1-NR1 disulfide-linked homodimer formation is requisite for efficient expression of functional, cell surface N-methyl-d-aspartate NR1/NR2 receptors. J. Biol. Chem. 2004, 279:14703-14712.
16. Perkinton M.S., Standen C.L., Lau K.-F., Kesavapany S., Byers H.L., Ward M., McLoughlin D.M., Miller C.C.J. The c-Abl tyrosine kinase phosphorylates the Fe65 adaptor protein to stimulate Fe65/amyloid precursor protein nuclear signaling. J. Biol. Chem. 2004, 279:22084-22091.
17. Proctor D.T., Coulson E.J., Dodd P.R. Reduction in post-synaptic scaffolding PSD-95 and SAP-102 protein levels in the Alzheimer inferior temporal cortex is correlated with disease pathology. J. Alzheimers Disease 2010, 21:795-811.
18. Richard K.L., Filali M., Préfontaine P., Rivest S. Toll-Like receptor 2 acts as a natural innate immune receptor to clear amyloid β1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease. J. Neurosci. 2008, 28:5784-5793.
19. Rutter A.R., Freeman F.M., Stephenson F.A. Further characterization of the molecular interaction between PSD-95 and NMDA receptors: the effect of the NR1splice variant and evidence for modulation of channel gating. J. Neurochem. 2002, 81:1298-1307.
20. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 2002, 298:789-791.
21. Simón A.M., Schiapparelli L., Salazar-Colocho P., Cuadrado-Tejedor M., Escribano L., López de Maturana R., Del Río J.J., Pérez-Mediavilla A., Frechilla D. Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Aβ levels. Neurobiol. Disease 2009, 33:69-78.
22. Snyder E.M., Nong Y., Almeida C.G., Paul S., Moran T., Choi E.Y., Nairn A.C., Salter M.W., Lombroso P.J., Gouras G.K., Greengard P. Regulation of NMDA receptor trafficking by amyloid-β. Nat. Neurosci. 2005, 8:1051-1058.
23. Thinakaran G., Koo E.H. Amyloid precursor protein trafficking processing and function. J. Biol. Chem. 2008, 283:29615-29619.